LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research

Photo from wikipedia

Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale, Marseille, France; ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d’Azur, Marseille,… Click to show full abstract

Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale, Marseille, France; ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d’Azur, Marseille, France; INSERM, U1016, Hôpital Cochin, 27 rue du Faubourg Saint Jacques, Paris, France; Hepatology Unit, Groupe hospitalier Cochin-Hôtel Dieu, AP-HP, Paris, France; Service d'Hépato-Gastro-Entérologie et d'Assistance Nutritive, Hôpital de Hautepierre, Strasbourg, France; Service d’Hépatologie, AP-HP, Hôpital Cochin, Paris, France; Université Paris Descartes, Paris, France

Keywords: reduced risk; hepatic steatosis; risk hepatic; cannabinoids reduced; paris france; france

Journal Title: Expert Review of Anti-infective Therapy
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.